| Literature DB >> 16140603 |
Marie-Claude Rousseau, Kurt Straif, Jack Siemiatycki.
Abstract
Entities:
Mesh:
Substances:
Year: 2005 PMID: 16140603 PMCID: PMC1280416 DOI: 10.1289/ehp.113-1280416
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Substances and mixtures that have been evaluated by IARC as human carcinogens and that are occupational exposures, based on Monograph Volumes 84–90.
| Substance or mixture | Occupation or industry in which the substance is found | Site(s) | IARC classification | IARC Monograph |
|---|---|---|---|---|
| Cobalt metal with tungsten carbide | Production of cemented carbides (hard-metal industry); tool grinders; saw filers; diamond polishers | Lung | 2A | 86 |
| Cobalt metal without tungsten carbide | Miners; production of alloys; processing of copper and nickel ore; glass and ceramic production; welders of cobalt-containing alloys | Uncertain | 2B | 86 |
| Cobalt sulfate and other soluble cobalt(II) salts | Electroplating and ceramic industries | Uncertain | 2B | 86 |
| Gallium arsenide | Production; microelectronics industry (integrated circuits and optoelectronic devices) | Uncertain | 1 | 86 |
| Indium phosphide | Production; microelectronics industry (integrated circuits and optoelectronic devices) | Uncertain | 2A | 86 |
| Vanadium pentoxide | Ore refining and processing; chemical manufacturing industry; maintenance of oil-fired boilers and furnaces | Uncertain | 2B | 86 |
| Inorganic lead compounds | Lead smelters; plumbers; solderers; occupations in battery recycling smelters; production of lead-acid batteries; printing press occupations; pigment production; construction and demolition | Lung | 2A | 87 |
| Formaldehyde | Production; pathologists; medical laboratory technicians; plastics; textile and plywood industry | Nasopharynx | 1 | 88 |
Not necessarily an exhaustive list of occupations/industries in which this agent is found; not all workers in these occupations/industries are exposed. The term “production” is used to indicate that this substance is man-made and that workers may be exposed in the production process.
We judged that the evidence for an association with this site was suggestive.
In reaching an overall evaluation of Group 1, the working group noted the potential for gallium arsenide to cause cancer through releases of a small amount of its arsenic, which behaves as inorganic arsenic at the sites where it is distributed. Arsenic and arsenic compounds have been evaluated as IARC Group 1, carcinogenic to humans. For arsenic in drinking water, the most recent IARC evaluation of arsenic [Volume 84; (IARC 2004)], there was sufficient evidence in humans that arsenic causes cancers of the urinary bladder, lung, and skin; the evidence for cancers of the liver and kidney was limited.
Absence of data on cancer in humans; the final evaluation for carcinogenicity was upgraded from 2B to 2A based on evidence of carcinogenicity in experimental animals.
The evidence was sufficient.